Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Next Science - Trading Halt (ASX:NXS)

The securities of Next Science Limited (‘NXS’) will be placed in trading halt at the request of NXS, pending it releasing an announcement. Unless ASX decides otherwise, the securities wi...read more

Novatti Group - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:NOV)

Strategy delivering results as quarterly sales revenue grows 53% year-on-year Highlights -- 53% year-on-year growth in quarterly sales revenue to $5.8m – new record -- 122% year-o...read more

Next Science - Investor Presentation - Q4 FY21 (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science - Quarterly Activity Report - 31 December 2021 (ASX:NXS)

Sydney, Australia Monday, 31 January 2022: Next Science Limited (ASX:NXS) (Next Science/Company) today announced its Appendix 4C Quarterly Cash Flow Report for the period 1 October 2021 to 31 Decemb...read more

Next Science - Appendix 4C - 31 December 2021 (ASX:NXS)

To view the Quarterly cash flow report for entities subject to Listing Rule 4.7B, download the attached PDF.

Next Science - Enhanced sales & distribution relationship with Zimmer (ASX:NXS)

Sydney, Australia Monday, 31 January 2022, Next Science Limited (ASX:NXS) (Next Science / Company) is pleased to announce that it has signed a US distribution agreement with Zimmer, Inc (a wholly ow...read more

Novatti Group - Proposed issue of securities (ASX:NOV)

To view the Proposed issue of securities, download the attached PDF.

Novatti Group - Appointment of Non-Executive Director (ASX:NOV)

Novatti Group Limited (ASX:NOV) (Novatti or Company), a leading fintech that enables businesses to pay and be paid, is pleased to announce the appointment of Abigail Cheadle as a non-executive direc...read more

Novatti Group - Update on New Banking Business (ASX:NOV)

Novatti Group Limited (ASX:NOV) (Novatti or Company), a leading fintech that enables businesses to pay and be paid, is pleased to provide an update on the development of its new banking business. ...read more

Next Sciences XPERIENCETM cleared by TGA for sale in Australia (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) is delighted to announce that its proprietary XPERIENCETM Surgical Solution has been cleared by Australia’s Therapeutic Goods Administration (TGA)...read more

Novatti Group - Acquiring Licences Awarded by Visa and Mastercard (ASX:NOV)

Highlights -- Novatti awarded Principal Acquiring licences by both Visa and Mastercard -- Adds to the strength of Novatti’s acquiring business and its rapidly growing customer base -- Wil...read more

Next Science - Q3 FY21 Investor Presentation (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science - Agreement signed with TELA Bio Inc (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science) is pleased to announce that it has signed a multi-year distribution agreement with NASDAQ listed medical technology company, TELA Bio, Inc in relation t...read more

Novatti Group - September Quarter Results Presentation (ASX:NOV)

To view the presentation, download the attached PDF.

Novatti Group - Quarterly Activities/Appendix 4C Cash Flow Report (ASX:NOV)

Highlights: -- $5.3m in quarterly sales revenue – new record and up 49% year-on-year -- Processing revenue up 100%+ year-on-year – marks 10 straight record quarters -- $19.9m - cash...read more

Viewing: 121 - 135 of 200 Previous | Next